Purchase Order HT001426PE001
Award Date 10/1/25
Potential Completion Date 9/30/27
Potential Value $90K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Patuxent River, MD 20670, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a firm fixed-price purchase order to Ortho-Clinical Diagnostics, Inc. valued at $83,698.23 for maintenance services and reagent/calibrator supplies supporting the Ortho Clinical Diagnostics VITROS 5600 Integration System Chemistry Analyzer. The contract, awarded on September 30, 2025, extends through September 29, 2026, and will be performed in Italy. This award represents a continuation of the agency's reliance on specialized laboratory diagnostic equipment...
- The Defense Health Agency awarded a firm fixed price purchase order to Ortho-Clinical Diagnostics Inc. for $170,317.80 to provide annual reagent shipments for the Walter Reed National Military Medical Center in Bethesda, Maryland. This contract has a completion date of September 8, 2026. Ortho-Clinical Diagnostics is a for-profit medical equipment manufacturer that has received numerous federal contracts and task orders to provide diagnostic instruments, reagents, and laboratory supplies to...
- The Defense Health Agency awarded a Firm Fixed Price Blanket Purchase Agreement call valued at $41,159.21 to Ortho-Clinical Diagnostics, Inc. for chemistry testing services. The contract, issued on August 15, 2025, with an ultimate completion date of September 30, 2025, represents a delivery order under a larger BPA vehicle. Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer headquartered in Raritan, New Jersey, will perform the work at its Raritan facility. This award was not...
- Ortho-Clinical Diagnostics, Inc. was awarded a $630,778.38 firm fixed-price purchase order by the Defense Health Agency on October 1, 2021 for blood bank testing equipment and supplies, specifically MTS A/B/D Mono & Reverse Group 5X20 analyzers. The contract, which carries an ultimate completion date of September 30, 2026, will be performed at the contractor's facility in Raritan, New Jersey. This award was made without a set-aside designation, indicating open competition. Ortho-Clinical...
- This is a $106,717.41 firm-fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer self-certified as a HUBZone joint venture. The contract is for the provision of ORTHO-CLINICAL BLOOD ANALYZER REAGENTS and has an ultimate completion date of November 20, 2028. Ortho-Clinical Diagnostics, Inc. has demonstrated expertise in supplying specialized medical diagnostic equipment and consumables to...
- The Defense Health Agency awarded a firm fixed-price delivery order to Ortho-Clinical Diagnostics, Inc. valued at $303,629.39 for cost-per-test laboratory chemistry analysis services utilizing the ORTHO VITROS Analyzer. This delivery order, effective through September 30, 2025, was issued without a set-aside designation under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule. Performance will be conducted at the contractor's facility in Raritan, New Jersey....
- The Defense Health Agency awarded a $17,947.90 firm fixed-price call order to Ortho-Clinical Diagnostics, Inc. under a Blanket Purchase Agreement for testing services associated with the Automated Chemistry Testing Platform serving the 88th Medical Group. This call order, issued on August 28, 2025, covers testing fees for fiscal year 2024 and will be completed by October 28, 2026. The work will be performed in Wright Patterson, Ohio. No set-aside designation was utilized for this award,...
- Ortho-Clinical Diagnostics, Inc. was awarded a $106,667.83 delivery order for automated blood grouping equipment and services by the Defense Health Agency on September 28, 2021, with a completion date of September 27, 2023. This firm fixed-price contract, which utilized no set-aside designation, represents a task order under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) schedule. The work is to be performed at the contractor's facility in Raritan, New...
- Ortho-Clinical Diagnostics, Inc. has been awarded a delivery order valued at $794,067.40 by the Defense Health Agency for orthovision supplies, reagents, and maintenance services in support of orthopedics clinical diagnostics. Issued on September 30, 2024, with an ultimate completion date of September 30, 2028, this firm fixed-price contract represents an unrestricted competitive award with no set-aside designation. The work will be performed at the company's headquarters in Raritan, New Jersey....
- This is a $849,897.70 firm fixed-price purchase order contract awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for blood bank testing supplies and services, with a period of performance ending on September 30, 2028. The contract does not have a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that has been awarded multiple Indefinite...